The AstraZeneca Covid-19 vaccine is safe to use, the European Union Medicines Agency said Thursday after a number of countries, including Germany, France and Italy, suspended it over concerns about blood clots in some recipients.
The finding came just two days after the regulator said Tuesday it reviewed new information and found there was “no indication” that there was any link between AstraZeneca’s vaccine and blood clotting. It added that the vaccine’s benefits continue to outweigh the risks.
“The committee has come to a clear scientific conclusion: this is a safe and effective vaccine,” European Medicines Agency chief Emer Cooke told a press conference after a probe by the body’s safety committee.
“The committee also concluded that the vaccine is not associated with an increase in the overall risk of thromboembolic events or blood clots.”